Showing all 6 results
Amodiaquine Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Yellow) or Film Coated Tablets. The strength is typically expressed in terms of the Amodiaquine Base.
Active Ingredient Strength (Base Equivalent) Salt Content (Approx) Role Amodiaquine HCl USP/BP 67.5 mg ~ 90 mg Pediatric (ACT Component) Amodiaquine HCl USP/BP 153 mg / 150 mg ~ 200 mg Adolescent / Co-blistered Amodiaquine HCl USP/BP 200 mg ~ 260 mg Standard Adult Dose Excipients Q.S. Microcrystalline Cellulose / Magnesium Stearate Direct Compression Artesunate & Amodiaquine Tablets
FreeProduct Composition & Available Strengths
We supply this product in both modern co-formulated Fixed-Dose Combination (FDC) single tablets and customized co-blistered kits, accurately titrated for adult and pediatric compliance.
Formulation Format Active Ingredient Mix (per Dose) Target Patient Segment Primary Clinical Function Infant / Pediatric FDC 25 mg Artesunate + 67.5 mg Amodiaquine Infants (2 months to less than 1 year) Early Intervention: Specially sized for pediatric dispersal. Toddler / Child FDC 50 mg Artesunate + 135 mg Amodiaquine Children (1 year to less than 6 years) Growth Tier: Optimized for easy pediatric administration. Youth / Adolescent FDC 100 mg Artesunate + 270 mg Amodiaquine Adolescents (6 years to less than 14 years) Intermediate Tier: Ensures accurate dosing for older children. Adult Potency FDC 100 mg + 270 mg (2 Tablets/Day) or 200 mg + 540 mg Adults & Children over 14 years Full Strength: Complete 3-day treatment matrix. Mefloquine Tablet
FreeProduct Composition & Configuration
We supply Mefloquine Hydrochloride in the internationally standardized strength calibrated for both adult therapeutic clearance and weekly travel prophylaxis.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Application Mefloquine Hydrochloride IP / BP / USP 250 mg
(Equivalent to 228 mg Mefloquine Base)
Oral Solid Uncoated Tablet (Cross-scored for exact pediatric dividing) Dual-Mode Antimalarial: High-dose 3-day treatment for active clearance, or low-dose once-weekly regimen for traveler chemoprophylaxis. Excipients Pharma Grade Microcrystalline Cellulose, Lactose, Magnesium Stearate The Disintegration Core: Engineered for uniform mechanical compression and rapid disintegration. Quinine Injection
FreeProduct Composition & Strength
We supply this product as a Sterile, Clear, Pale Yellow Aqueous Solution in glass ampoules.
Active Ingredient Concentration Total Content & Format Quinine Dihydrochloride BP 300 mg / ml 600 mg in 2 ml Glass Ampoule Excipients Water for Injection Preservative-Free Solution *Pack Sizes: Tray of 10 Ampoules or Box of 100 Ampoules.








